Notably, some genetic traits associated with increased PD risk, such as LRRK2 and PRKN pathogenic variants [34], are associated with lower likelihood of both olfactory loss and underlying alpha-synucleinopathy [59]. Here, PRKN is linked to synucleinopathy.